Clinical Trials Directory

Trials / Completed

CompletedNCT05975879

A Study of the Feasibility of Using the Dietary Supplement "ARTNEO" in Patients With Osteoathritis

Multicenter, Prospective, Double-blind, Placebo-controlled, Randomized Study of the Feasibility of Using the Dietary Supplement "ARTNEO®", Capsules for Oral Administration in Patients With Stage II-III Primary Knee Osteoarthritis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
212 (actual)
Sponsor
NPO Petrovax · Industry
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical study is to evaluate the effectiveness of the properties that support the functional state of the joints and the safety of the dietary supplement for food ARTNEO®, oral capsules, in patients with stage II-III primary osteoarthritis of the knee joint. The main questions it aims to answer are: 1. To evaluate the effectiveness of the joint functional state-supporting properties of dietary supplement ARTNEO®, capsules for oral administration, in patients with stage II-III primary osteoarthritis of the knee joint; 2. To evaluate the safety of dietary supplement ARTNEO®, capsules for oral administration, in patients with stage II-III primary osteoarthritis of the knee joint. Participants will be randomly distributed equally among two groups: * Group 1 "ARTNEO" (106 people): patients take the study dietary supplement ARTNEO®, 1 capsule 1 time per day for 6 months; * Group 2 "Placebo" (106 people): patients take placebo 1 capsule 1 time per day for 6 months.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTundenaturated collagen type II, methylsulfonylmethane, boswellia serrata, vitamin D3 (cholecalciferol), vitamin C (ARTNEO)Release form: capsules with an average weight of 585 mg. Active ingredients: MCM (methylsulfonylmethane) 300 mg, vitamin C (ascorbic acid) 80 mg, boswellia extract (65% boswellic acids) 50.05 mg, undenatured (native) type II collagen 40 mg, vitamin D3 (cholecalciferol) 400 IU. Suggested Use: Adults, 1 capsule daily with meals.
DIETARY_SUPPLEMENTPlaceboRelease form: capsules with an average weight of 585 mg. No active ingredients.

Timeline

Start date
2022-05-31
Primary completion
2023-02-28
Completion
2023-04-17
First posted
2023-08-04
Last updated
2024-08-02

Locations

12 sites across 1 country: Russia

Source: ClinicalTrials.gov record NCT05975879. Inclusion in this directory is not an endorsement.